<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2026-11-10</publicationDate>
    
        <volume>19</volume>
        <issue>4</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>74196</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Preventive Administration of Glucocorticoids Does not Suppress Lipopolysaccharide-Induced Neuroinflammation</title>

    <authors>
	 


      <author>
       <name>Elena Lebedeva</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Ekaterina Kukushkina</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Viktoriya Maystrenko </name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Regina Cherkassova </name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	 


      <author>
       <name>Marina Karpenko </name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Institute of Biomedical Systems and Biotechnology, Peter the Great St. Petersburg Poly-technic University, Saint Petersburg, Russia</affiliationName>
    

		
		<affiliationName affiliationId="2">Laboratory of Neurochemistry, I.P. Pavlov Dept. of Physiology, Institute of Experimental Medicine, Saint Petersburg, Russia</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Glucocorticoids are widely prescribed to limit inflammation, yet their action within the brain may differ depending on when they are given relative to an inflammatory challenge. This work examined how dexamethasone and methylprednisolone, administered before an endotoxin challenge, modify the early and delayed molecular and morphological consequences of systemic endotoxemia. Adult male rats of the Wistar strain were allocated to saline, bacterial endotoxin (1 mg per kg body weight), either steroid alone (2 mg per kg body weight), or a steroid given two hours in advance of the endotoxin. Brain tissue was sampled two days and ten days after the challenge. Sections of prefrontal cortex and hippocampus stained with haematoxylin and eosin were examined for structural alterations, and transcript abundance of TNF-α, IL-1β, iNOS and the microglial marker IBA-1 was measured in the same regions by reverse-transcription quantitative PCR. Endotoxin raised transcript abundance of all four markers in both regions at both sampling points, together with histological signs of neuronal injury, namely acidophilic neurons and reduced neuronal cellularity. Prior steroid exposure lowered part of the two-day transcriptional response, whereas several markers remained above control values on day ten, most consistently in the hippocampus; neither steroid given alone evoked a reproducible transcriptional response. Because the doses employed were not equipotent, the two steroids were not compared with each other. Partial and non-sustained attenuation, together with residual transcriptional and structural alterations on day ten, is compatible with a priming-like shift in reactivity of the neuroinflammatory compartment, and indicates that the timing of steroid administration deserves consideration during systemic inflammation.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol19no4/preventive-administration-of-glucocorticoids-does-not-suppress-lipopolysaccharide-induced-neuroinflammation/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Dexamethasone</keyword>
      

      
        <keyword> Hippocampus</keyword>
      

      
        <keyword> Lipopolysaccharide (LPS)</keyword>
      

      
        <keyword> Methylprednisolone</keyword>
      

      
        <keyword> Neuroinflammation</keyword>
      

      
        <keyword> Prefrontal cortex</keyword>
      
</keywords>
  </record>
</records>